Repository logo


Direct interaction of whole-inactivated influenza A and pneumococcal vaccines enhances influenza-specific immunity

dc.contributor.authorDavid, SCen_AU
dc.contributor.authorNorton, Ten_AU
dc.contributor.authorTyllis, Ten_AU
dc.contributor.authorWilson, JJen_AU
dc.contributor.authorSingleton, EVen_AU
dc.contributor.authorLaan, Zen_AU
dc.contributor.authorDavies, Jen_AU
dc.contributor.authorHirst, TRen_AU
dc.contributor.authorComerford, Ien_AU
dc.contributor.authorMcColl, SRen_AU
dc.contributor.authorPaton, JCen_AU
dc.contributor.authorAlsharifi, Men_AU
dc.date.accessioned2026-08-12T07:17:30Zen_AU
dc.date.issued2019-05-20en_AU
dc.date.statistics2026-07-29en_AU
dc.description.abstractThe upper respiratory tract is continuously exposed to a vast array of potentially pathogenic viruses and bacteria. Influenza A virus (IAV) has particular synergism with the commensal bacterium Streptococcus pneumoniae in this niche, and co-infection exacerbates pathogenicity and causes significant mortality. However, it is not known whether this synergism is associated with a direct interaction between the two pathogens. We have previously reported that co-administration of a whole-inactivated IAV vaccine (γ-Flu) with a whole-inactivated pneumococcal vaccine (γ-PN) enhances pneumococcal-specific responses. In this study, we show that mucosal co-administration of γ-Flu and γ-PN similarly augments IAV-specific immunity, particularly tissue-resident memory cell responses in the lung. In addition, our in vitro analysis revealed that S. pneumoniae directly interacts with both γ-Flu and with live IAV, facilitating increased uptake by macrophages as well as increased infection of epithelial cells by IAV. These observations provide an additional explanation for the synergistic pathogenicity of IAV and S. pneumoniae, as well as heralding the prospect of exploiting the phenomenon to develop better vaccine strategies for both pathogens. © 2019, The Author(s), under exclusive licence to Springer Nature Limited.en_AU
dc.description.sponsorshipThe authors thank Adelaide University Microscopy (Adelaide, Australia) for assistance in sample preparation and operation of the FEI Tecnai G2 Spirit TEM. We also acknowledge the following funding sources supporting this research: an Australian Institute of Nuclear Science and Engineering (AINSE) Research Award (ALNGRA15517; to M.A.); an Australian Postgraduate Award and Gamma Vaccines Pty Ltd research sponsorship (to S.C.D.); and a National Health and Medical Research Council Senior Principal Research Fellowship (awarded to J.C.P.).en_AU
dc.format.mediumPrint-Electronicen_AU
dc.identifier.citationDavid, S. C., Norton, T., Tyllis, T., Wilson, J. J., Singleton, E. V., Laan, Z., Davies, J., Hirst, T. R., Comerford, I., McColl, S. R., Paton, J. C., & Alsharifi, M. (2019). Direct interaction of whole-inactivated influenza A and pneumococcal vaccines enhances influenza-specific immunity. Nature Microbiology, 4(8), 1316–1327. doi:10.1038/s41564-019-0443-4en_AU
dc.identifier.issn2058-5276en_AU
dc.identifier.issue8en_AU
dc.identifier.journaltitleNature Microbiologyen_AU
dc.identifier.pagination1316-1327en_AU
dc.identifier.urihttps://doi.org/10.1038/s41564-019-0443-4en_AU
dc.identifier.urihttps://apo.ansto.gov.au/handle/10238/17316en_AU
dc.identifier.volume4en_AU
dc.languageEnglishen_AU
dc.language.isoenen_AU
dc.publisherSpringer Natureen_AU
dc.subjectVaccinesen_AU
dc.subjectInfluenzaen_AU
dc.subjectPneumococcusen_AU
dc.subjectVirusesen_AU
dc.subjectBacteriaen_AU
dc.subjectMacrophagesen_AU
dc.subjectPathogensen_AU
dc.subjectSynergismen_AU
dc.titleDirect interaction of whole-inactivated influenza A and pneumococcal vaccines enhances influenza-specific immunityen_AU
dc.typeJournal Articleen_AU
dcterms.dateAccepted2019-04-02en_AU

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.66 KB
Format:
Plain Text
Description:

Collections